Company

KalVista Pharmaceuticals, Inc. (KALV)

Standardized SEC financial data for KalVista Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001348911 · NASDAQ · Pharmaceutical Preparations.

Operating margin

-376.0%

Net margin

-366.9%

Revenue growth (YoY)

294.0%

Return on equity

-192.3%

Free cash flow

-$153.3M

Current ratio

5.35×

EPS (diluted)

$-3.69

Ratios for fiscal year 2024, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$12.7M	—	—	—	$50.0M	—
R&D expense	$40.2M	$41.3M	$70.2M	$80.3M	$86.2M	$71.7M
SG&A expense	$13.0M	$16.6M	$26.4M	$30.6M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$15.8M	$50.6M	$30.7M	$56.2M	$31.8M	$132.3M
Total current assets	$88.7M	$264.3M	$193.6M	$172.3M	$225.7M	$241.7M
Property, plant & equipment	$2.0M	$1.8M	$2.2M	$2.9M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$44.8M	-$30.2M	-$78.1M	-$75.3M	-$89.2M	-$152.9M
Capital expenditures	$220K	$82K	$931K	$1.2M	$42K	$434K
Free cash flow	-$45.0M	-$30.3M	-$79.1M	-$76.5M

Get KALV data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/KALV/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/KALV/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View KALV filings on SEC EDGAR →